Hepatobiliary scintigraphy after Kasai procedure for biliary atresia: clinical correlation and prognostic value. 2007

Marco Castagnetti, and Mark Davenport, and Sarah Tizzard, and Nedim Hadzic, and Giorgina Mieli-Vergani, and Muriel Buxton-Thomas
Department of Paediatric Surgery, King's College Hospital, SE5 9RS London, UK.

OBJECTIVE Kasai portoenterostomy (KP) is regarded as first-line treatment for biliary atresia, although its postoperative course is often unpredictable. Hepatobiliary scintigraphy using technetium-labeled iminodiacetic acid derivatives offers a dynamic, objective assessment both of parenchymal liver function and restored biliary excretion. The value of postoperative radionuclide scans was assessed prospectively in a large population of post-KP infants. METHODS Radionuclide scans consisted of an intravenous dose of 20 MBq of 99mTc mebrofenin iminodiacetic acid and subsequent gamma camera imaging. Four scan variables were evaluated: the hepatic extraction fraction (HEF; ie, initial liver uptake divided by the peak vascular uptake), the half-life of tracer excretion (TEX), the shape of the excretion curve, and the presence of activity in the Roux loop at 4 hours postinjection. All infants had type 3 biliary atresia with a median age at KP of 59 days (24-120 days). To assess predictive value, outcome (clearance of jaundice and need for transplant) was assessed at 6 months (for 1-week scan) and 2 years (for 6-month scan). RESULTS Eighty-seven infants underwent a radionuclide scan at 1 week post-KP. The median HEF was 34% (10%-90%). No relationship could be identified between HEF (P = .2) or excretion curve shape (P = .9) and outcome (at 6 months), and there were too few examples of a measurable TEX to allow meaningful comparison. The only predictive element at this time point was Roux loop activity (positive predictive value, 79%; negative predictive value, 53%; for "good" isotope bowel activity). Forty-four infants completed a second scan at 6 months. Median HEF increased from a baseline of 37% (11%-90%) to 64% (8%-100%) (P < .0001), although there was no significant intercorrelation (P = .12). The most predictive variables (of outcome at 2 years) were curve shape (positive predictive value, = 95%, negative predictive value, 82%) and TEX, and the least predictive was now Roux loop activity. CONCLUSIONS Early (at 7 days) hepatic scintigraphy is not predictive of poor outcome in general, although Roux loop activity does indicate later success. Later hepatic scintigraphy (at 6 months) allows a detailed assessment of dynamic liver function with biliary excretion variables predictive of outcome in the medium term.

UI MeSH Term Description Entries
D007098 Imino Acids Carboxylic acids that contain an imino group (C Amino Acids, Secondary,Acids, Secondary Amino,Secondary Amino Acids,Acids, Imino
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D011171 Portoenterostomy, Hepatic Operation for BILIARY ATRESIA by anastomosis of the BILE DUCTS into the JEJUNUM or DUODENUM. Hepatic Portoenterostomy,Hepatoportoenterostomy,Kasai Procedure,Hepatic Portoenterostomies,Hepatoportoenterostomies,Portoenterostomies, Hepatic
D011184 Postoperative Period The period following a surgical operation. Period, Postoperative,Periods, Postoperative,Postoperative Periods
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective

Related Publications

Marco Castagnetti, and Mark Davenport, and Sarah Tizzard, and Nedim Hadzic, and Giorgina Mieli-Vergani, and Muriel Buxton-Thomas
January 2000, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
Marco Castagnetti, and Mark Davenport, and Sarah Tizzard, and Nedim Hadzic, and Giorgina Mieli-Vergani, and Muriel Buxton-Thomas
October 2017, Pediatric surgery international,
Marco Castagnetti, and Mark Davenport, and Sarah Tizzard, and Nedim Hadzic, and Giorgina Mieli-Vergani, and Muriel Buxton-Thomas
May 2010, American journal of surgery,
Marco Castagnetti, and Mark Davenport, and Sarah Tizzard, and Nedim Hadzic, and Giorgina Mieli-Vergani, and Muriel Buxton-Thomas
November 2015, Revista espanola de anestesiologia y reanimacion,
Marco Castagnetti, and Mark Davenport, and Sarah Tizzard, and Nedim Hadzic, and Giorgina Mieli-Vergani, and Muriel Buxton-Thomas
January 2022, Pediatrics international : official journal of the Japan Pediatric Society,
Marco Castagnetti, and Mark Davenport, and Sarah Tizzard, and Nedim Hadzic, and Giorgina Mieli-Vergani, and Muriel Buxton-Thomas
March 1984, Clinical nuclear medicine,
Marco Castagnetti, and Mark Davenport, and Sarah Tizzard, and Nedim Hadzic, and Giorgina Mieli-Vergani, and Muriel Buxton-Thomas
November 2023, BMC pediatrics,
Marco Castagnetti, and Mark Davenport, and Sarah Tizzard, and Nedim Hadzic, and Giorgina Mieli-Vergani, and Muriel Buxton-Thomas
October 2019, Nuclear medicine and molecular imaging,
Marco Castagnetti, and Mark Davenport, and Sarah Tizzard, and Nedim Hadzic, and Giorgina Mieli-Vergani, and Muriel Buxton-Thomas
February 2005, Journal of pediatric surgery,
Marco Castagnetti, and Mark Davenport, and Sarah Tizzard, and Nedim Hadzic, and Giorgina Mieli-Vergani, and Muriel Buxton-Thomas
December 2020, Chinese medical journal,
Copied contents to your clipboard!